top of page

QMS Remediation and FDA 483 Response Support

When a quality system needs more than a procedure rewrite

A quality management system fails in visible ways: repeating deviations, CAPAs that do not hold, overdue investigations, training that does not match practice, and inspection observations that point to the system rather than a single bad batch. Remediation is the work of putting that system back into a state of control, with evidence that the changes are real.​

​

GxP Auditing and Consulting Services provides QMS remediation support led by Ramzi W. Kozal, CQA, an independent GxP lead auditor with nearly 30 years of experience and 300+ GxP audits led across the US and Europe, including Italy. The work includes gap assessments, quality system improvement, and support responding to FDA 483s and warning letters. It also includes practical work in widely used QMS platforms, specifically Veeva Vault and TrackWise.

​

The aim is not to add documents for their own sake. It is to make deviation handling, CAPA, change control, document control, and management oversight work well enough to stand up in an audit or inspection.

​

​

Veeva Vault and TrackWise, as they are actually used

Many companies already own a capable QMS platform and still have a broken process. Records live in Veeva Vault or TrackWise, but workflows are bypassed, fields are incomplete, overdue items accumulate, and users treat the system as a filing cabinet rather than the controlled process. Remediation has to address both the procedure and the way the tool is configured and used.

​

Support can include reviewing how deviations, CAPAs, complaints, change controls, or training records are flowing through Veeva Vault or TrackWise; identifying where the process and the system do not match; and recommending changes to workflow, data quality, and oversight. This is quality-system consulting informed by audit practice, not a software implementation project sold by the platform vendor.

​

If computerized-system validation or 21 CFR Part 11 questions are part of the same problem, they can be handled with the data integrity and CSV service rather than ignored because they sit in a different “IT” bucket.

​

​

FDA 483 and warning letter response

When an inspection has already produced a Form 483 or a warning letter, the quality of the response matters as much as the speed. A response has to show that the firm understands the observation, has found the root cause, and has a credible CAPA with owners, due dates, and effectiveness checks. Over-promising, under-scoping, or fixing only the example the investigator happened to see are common failures.

​

Support can include review of the observations and the underlying records, help developing a response strategy, drafting or reviewing the formal response, and follow-up during the period after submission. The pricing page lists a dedicated FDA 483 and warning letter response package, along with add-on support if the work has to continue.

​

This practice also provides mock inspections and inspection-readiness work before an inspection happens. Ramzi has also hosted and defended 20+ FDA inspections with zero critical observations. If you still have time before an announced or expected inspection, that route is usually better than waiting to remediate under a 483.

​

​

How remediation is structured​

Work starts with a gap assessment: what the quality system is supposed to do, what the records show it actually does, and which gaps create the most regulatory risk. From there, the engagement can include procedure and process revision, CAPA design, training, and a period of implementation support. The scope may be a single process, such as deviation management, or a wider QMS rebuild.

​

Remediation can be performed remotely (worldwide) or on site (US and international). It is often most effective when document review, system review in Veeva Vault or TrackWise, and interviews with process owners are combined. Progress is measured by whether investigations improve, whether CAPAs close on time and stay effective, and whether the system would be explainable to an investigator.

​

Related services can be folded in when the gap assessment shows they are needed: vendor or CDMO requalification, CRO and GCP oversight, data integrity or CSV work, and a later mock inspection to test whether the system now holds.

​

​

Who this is for

QMS remediation is for pharmaceutical, radiopharmaceutical, biotech, and dietary supplement organizations that already know the current system is not good enough, whether that knowledge came from internal metrics, a vendor audit, a mock inspection, or a regulatory observation. It is also for teams that have the software in place and still cannot get consistent, inspection-ready records out of it.

​

To discuss a quality system assessment, Veeva Vault or TrackWise process review, or 483 response support, contact GxP Auditing and Consulting Services or call (239) 207-8132. A consultation can determine whether you need a focused CAPA repair, a broader remediation plan, or inspection-readiness work first.

Frequently Asked Questions

Do you implement Veeva Vault or TrackWise as a software vendor?

No. The service is quality-system remediation and audit-informed consulting in environments that already use Veeva Vault or TrackWise. It focuses on process, record quality, workflow, and inspection readiness, not on selling or installing the platform.

​

Can you help write an FDA 483 or warning letter response?

Yes. Support can include review of the findings and records, response strategy, drafting or review of the formal response, and follow-up communication support. A defined package for this work is listed on the pricing page.

​

Is remediation only for companies that already have a 483?

No. Many engagements begin after internal audits, repeating deviations, or a mock inspection. Fixing the system before an inspection is usually better than remediating under an agency observation.

​

What regulations does QMS work follow?

The applicable framework depends on the operation. That may include 21 CFR Parts 210 and 211, 212, 111, and Part 11, as well as GCP, GLP, GDP, or applicable ISO requirements.

​

Can this be combined with a mock inspection?

Yes. A gap assessment or remediation plan can be followed by a mock FDA or EMA inspection to test whether the changes would stand up under inspection conditions.

bottom of page